{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T11:23:58Z","timestamp":1764588238362},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,10]]},"DOI":"10.7759\/cureus.18636","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T09:42:41Z","timestamp":1633858961000},"source":"Crossref","is-referenced-by-count":1,"title":["A Challenging Case of Persisting Hypokalemia Secondary to Gitelman Syndrome"],"prefix":"10.7759","author":[{"given":"Mohamad","family":"Bakir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossam Aldin  G","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3590","article-title":"Gitelman syndrome","volume":"344","author":"Park PG Jr","year":"2012","unstructured":"Park PG Jr, Frankl FEK. Gitelman syndrome. BMJ. 2012, 344:e3590. 10.1136\/bmj.e3590","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-3-22","article-title":"Gitelman syndrome","volume":"3","author":"Knoers NV","year":"2008","unstructured":"Knoers NV, Levtchenko EN. Gitelman syndrome. Orphanet J Rare Dis. 2008, 3:22. 10.1186\/1750-1172-3-22","journal-title":"Orphanet J Rare Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165660","article-title":"Are the clinical presentations (phenotypes) of Gitelman's and Bartter's syndromes gene mutations driven by their effects on intracellular pH, their \"pH\" enotype?","volume":"21","author":"Cal\u00f2 LA","year":"2020","unstructured":"Cal\u00f2 LA, Davis PA. Are the clinical presentations (phenotypes) of Gitelman's and Bartter's syndromes gene mutations driven by their effects on intracellular pH, their \"pH\" enotype?. Int J Mol Sci. 2020, 21:5660. 10.3390\/ijms21165660","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000321","article-title":"Understanding the mechanisms of angiotensin II signaling involved in hypertension and its long-term sequelae: insights from Bartter's and Gitelman's syndromes, human models of endogenous angiotensin II signaling antagonism","volume":"32","author":"Cal\u00f2 LA","year":"2014","unstructured":"Cal\u00f2 LA, Davis PA, Rossi GP. Understanding the mechanisms of angiotensin II signaling involved in hypertension and its long-term sequelae: insights from Bartter's and Gitelman's syndromes, human models of endogenous angiotensin II signaling antagonism. J Hypertens. 2014, 32:2109-19; discussion 2119. 10.1097\/HJH.0000000000000321","journal-title":"J Hypertens"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.09.046","article-title":"Gitelman syndrome: consensus and guidance from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"91","author":"Blanchard A","year":"2017","unstructured":"Blanchard A, Bockenhauer D, Bolignano D, et al.. Gitelman syndrome: consensus and guidance from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2017, 91:24-33. 10.1016\/j.kint.2016.09.046","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2016.31.1.47","article-title":"Mutations in SLC12A3 and CLCNKB and their correlation with clinical phenotype in patients with Gitelman and Gitelman-like syndrome","volume":"31","author":"Lee JW","year":"2016","unstructured":"Lee JW, Lee J, Heo NJ, Cheong HI, Han JS. Mutations in SLC12A3 and CLCNKB and their correlation with clinical phenotype in patients with Gitelman and Gitelman-like syndrome. J Korean Med Sci. 2016, 31:47-54. 10.3346\/jkms.2016.31.1.47","journal-title":"J Korean Med Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1071616","article-title":"Hypomagnesemia","volume":"10","author":"Agus ZS","year":"1999","unstructured":"Agus ZS. Hypomagnesemia. J Am Soc Nephrol. 1999, 10:1616-22. 10.1681\/ASN.V1071616","journal-title":"J Am Soc Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-212375","article-title":"Management of a severe case of Gitelman syndrome with poor response to standard treatment","volume":"2016","author":"Koudsi L","year":"2016","unstructured":"Koudsi L, Nikolova S, Mishra V. Management of a severe case of Gitelman syndrome with poor response to standard treatment. BMJ Case Rep. 2016, 2016:bcr2015212375. 10.1136\/bcr-2015-212375","journal-title":"BMJ Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014030293","article-title":"Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome","volume":"26","author":"Blanchard A","year":"2015","unstructured":"Blanchard A, Vargas-Poussou R, Vallet M, et al.. Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome. J Am Soc Nephrol. 2015, 26:468-75. 10.1681\/ASN.2014030293","journal-title":"J Am Soc Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/73847-a-challenging-case-of-persisting-hypokalemia-secondary-to-gitelman-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:47Z","timestamp":1707507047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/73847-a-challenging-case-of-persisting-hypokalemia-secondary-to-gitelman-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,10]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.18636","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,10]]}}}